Form 4: Hanover Insurance EVP Exercises, Sells Stock Options
Insider Transaction Report
Hanover Insurance Group's Executive Vice President, Denise Lowsley, exercised stock options and sold the resulting shares, realizing a gain.
Summary
- Executive Vice President Denise Lowsley exercised 5,626 stock options at an exercise price of $118.54 per share.
- Simultaneously, Lowsley sold 5,626 shares of common stock at a price of $168.15 per share.
- These transactions occurred on August 1, 2025, and were made pursuant to a Rule 10b5-1 plan.
- The options exercised vested in three equal parts on February 28, 2021, February 28, 2022, and February 28, 2023, and were set to expire on February 28, 2030.
- Following these reported transactions, Lowsley beneficially owns 5,119.028 shares of common stock.
- Her beneficial ownership includes 73 shares acquired through The Hanover Insurance Group Inc.'s 2023 Employee Stock Purchase Plan on June 30, 2025.
Sentiment
Score: 7
Explanation: The filing details a routine executive compensation transaction involving the exercise and sale of stock options. This is a neutral event for the company's operational performance but positive for the executive's personal gain, reflecting the functioning of the company's incentive programs.
Positives
- Executive Vice President Denise Lowsley realized a gain from exercising stock options and selling shares, indicating a successful compensation event.
- The exercise and sale of options is a routine transaction for executive compensation, demonstrating the company's equity incentive program is functioning as intended.
- The transaction was conducted under a Rule 10b5-1 plan, indicating it was pre-planned and not based on immediate insider information.
Negatives
- The sale of 5,626 shares by an executive, even as part of an option exercise, represents a reduction in direct insider holdings.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The transaction is a routine executive compensation event and does not indicate a significant change in company fundamentals or strategy. It reflects the normal course of executive equity incentive programs.
- Employees: The filing demonstrates the functioning of the company's equity compensation plans, including the Employee Stock Purchase Plan.
Key Dates
| Date | Description |
|---|---|
| 2021-02-28 | First vesting date for 1/3 of the stock options. |
| 2022-02-28 | Second vesting date for 1/3 of the stock options. |
| 2023-02-28 | Third and final vesting date for 1/3 of the stock options. |
| 2025-06-30 | Acquisition of 73 shares via The Hanover Insurance Group Inc.'s 2023 Employee Stock Purchase Plan. |
| 2025-08-01 | Date of option exercise and simultaneous sale of common stock. |
| 2025-08-05 | Date of filing signature. |
| 2030-02-28 | Expiration date of the exercised stock options. |
Recommendation
holdThe Form 4 filing details a standard executive compensation event involving the exercise and sale of stock options. This type of transaction is routine and does not provide new information regarding the company's operational performance, financial health, or strategic direction that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as the filing does not alter the investment thesis.
Keywords
Hanover Insurance Group, THG, SEC Form 4, Insider Trading, Stock Options, Executive Compensation, Share Sale, Denise Lowsley, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.